Home > Boards > Free Zone > User's Groups > Animal Sector

>>> EPA Validates Neogen's Disinfectant for Use Against COVID-19

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gfp927z Member Profile
 
Followed By 63
Posts 24,163
Boards Moderated 74
Alias Born 03/22/05
160x600 placeholder
Covid-19 Vaccines and Rare Blood Clots: Are Women at Greater Risk?
Scientists are trying to understand why women appear to be more vulnerable than men to a potentially deadly blood-clotting condition reported among a tiny number of recipients of Johnson & Johnson's Covid-19 vaccine.
Economic Growth Is Set to Surge. Hiring Might Not Keep Up.
Correction to Indianapolis Shooting Article
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility -- 11th Update
Correction to Indianapolis Mass Shooting Article
Correction to Indianapolis Shooting Article at 1:07 p.m. ET
After FedEx Shooting, Indianapolis Grieves
Travel Boom Coming, Expedia CEO Says: 'Hotels Will Come Screaming Back'
Expat Americans Fly Home for Covid-19 Vaccination Shots
In Punishing Russia for SolarWinds, Biden Upends U.S. Convention on Cyber Espionage
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility -- 10th Update
Roger Stone Is Sued as U.S. Government Alleges Unpaid Taxes -- Update
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility -- 9th Update
Roger Stone Is Sued as U.S. Government Alleges Unpaid Taxes
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility -- 8th Update
Top Company News of the Day
J&J, Morgan Stanley, Coinbase: Stocks That Defined the Week
NASA Picks SpaceX to Build New Lunar Lander -- 2nd Update
Lilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone -- Update
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility -- 7th Update
Stocks End Week With Fresh Records--Update
gfp927z   Saturday, 08/29/20 12:47:29 PM
Re: None
Post # of 11 
>>> EPA Validates Neogen's Disinfectant for Use Against COVID-19


Zacks

August 17, 2020


https://finance.yahoo.com/news/epa-validates-neogens-disinfectant-against-131201025.html


NEOGEN Corporation NEOG announced that the U.S. Environmental Protection Agency (“EPA”) has validated the effectiveness of the company’s BioSentry 904 Disinfectant against the COVID-19-causing SARS-CoV-2 virus, when used per the revised label instructions. The disinfectant, which is a hospital-grade broad-spectrum sanitizer, has been recommended for use on washable, hard and non-porous surfaces (cabinets and counters, for example).

Notably, the EPA had earlier granted an emergency approval to the BioSentry 904 Disinfectant to be used against SARS-CoV-2 under the agency’s emerging-pathogens provision.

Apart from the BioSentry 904 Disinfectant, NEOGEN also offers Parvosol II RTU Disinfectant, Synergize Disinfectant, COMPANION Disinfectant, COMPANION Disinfectant Wipes and Peraside 5% Disinfectant. These also carry the EPA’s emerging-pathogen approvals to combat the spread of COVID-19.

With the recent clearance, NEOGEN aims to strengthen its Rodenticides, Insecticides & Disinfectants business on a global scale. For investors’ note, the Rodenticides, Insecticides & Disinfectants business is a component of the company’s broader Animal Safety arm.

Significance of the Approval

Per the company, the EPA’s approval of BioSentry validates the effectiveness of the product against a broader range of human-illness causing pathogens. The coronavirus outbreaks in the food industry, among others, highlight the importance of products that effectively fight against the same.

Industry Prospects

Per a report by Grand View Research, the global animal health market size was valued at $47.1 billion in 2019 and is expected to witness a CAGR of 5.8% between 2020 and 2027. Factors like rising demand for protein food and increase in incidents of food-borne diseases globally are expected to drive the market.

Given the market potential, the approval is expected to enhance the company’s business.

Recent Developments in Animal Safety

Of late, NEOGEN has been witnessing a slew of developments within its Animal Safety segment.

The company’s AquaPrime Activator was reviewed by the Organic Materials Review Institute’s (“OMRI”) in August and was determined to be in compliance with the USDA National Organic Program, with usage restrictions. In the same month, NEOGEN completed the previously announced acquisition of the U.S. (including territories) rights to Elanco’s StandGuard Pour-on for horn fly and lice control in beef cattle and related assets.

In May, NEOGEN launched the enhanced version of its Igenity Beef profile, which is a genomic test for commercial cattle. In the same month, the company received the OMRI’s clearance for its AquaPrime NeoKlor water disinfectant, which was in compliance with the USDA National Organic Program with certain usage restrictions.

In April, Neogen in association with Superior Livestock Auction launched a commercial beef certification program, Igenity Branded, verified by a genomic test.

Price Performance
Shares of the company have gained 6.8% in the past year against the industry’s 5.2% fall and the S&P 500’s 15.4% growth.


Zacks Rank & Key Picks
Currently, Neogen carries a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are QIAGEN N.V. QGEN, Thermo Fisher Scientific Inc. TMO and Hologic, Inc. HOLX.

QIAGEN’s long-term earnings growth rate is estimated at 22.3%. It currently flaunts a Zacks Rank #1. (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Thermo Fisher’s long-term earnings growth rate is estimated at 15%. It currently carries a Zacks Rank #2 (Buy).

Hologic’s long-term earnings growth rate is estimated at 15.5%. The company presently sports a Zacks Rank #1.

<<<




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences